Broncho-munal, capsules 7mg, 30pcs

Composition

1 capsule lyophilized bacterial lysate:

Streptococcus pneumoniae,

Haemophilus influenzae,

Klebsiella pneumoniae,

Klebsiella ozaenae,

Staphylococcus aureus,

Streptococcus viridans,

Streptococcus pyogenes,

Moraxella catarrhalis 7 mg

Auxiliary substances:

propyl gallate (anhydrous),

sodium glutamate (anhydrous),

mannitol,

magnesium stearate,

pregelatinated starch,

indigotine,

titanium dioxide,

gelatin.

Pharmacological action

Immunomodulatory drug of bacterial origin.

It stimulates both a local cellular and humoral immune response in the respiratory mucosa, as well as a systemic immune response.

The drug stimulates the activity of alveolar macrophages, increases the number and activity of T-lymphocytes, activates peripheral monocytes, increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract, stimulates the production of protective adhesive molecules, reduces the concentration of IgE antibodies in the blood, and also increases the production of cytokines.

Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.

Indications

• infectious respiratory disease (in the complex therapy as immunomodulatory agent) in children aged 6 months to 12 years (for capsules 3.5 mg);
• infectious respiratory disease (in the complex therapy as immunomodulatory agent) in adults and children older than 12 years (for capsules 7 mg)
• for the prevention of recurrent infections of the upper and lower respiratory tract (chronic bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media).

Use during pregnancy and lactation

The use of Broncho-munal® during pregnancy and lactation is possible only if the intended benefit to the mother exceeds the potential risk to the fetus or infant.

Contraindications

Increased individual sensitivity to the components of the drug.

Side effects

During the entire period of clinical use of the drug, undesirable effects were extremely rare.

In some cases:  disorders of the digestive system (epigastric pain, nausea, vomiting, diarrhea), fever.

If the side effects are mild, discontinuation of the drug is not required. If a hypersensitivity reaction occurs, discontinuation of the drug is recommended.

Interaction

The drug can be used simultaneously with other medications, including antibiotics.

How to take, course of use and dosage

Adults and children over 12 years of age:  Broncho-munal® is prescribed at a dose of 7 mg; children aged 6 months to 12 years are prescribed Broncho-munal® P at a dose of 3.5 mg.

The drug is taken in the morning on an empty stomach for 1 capsule/day. If the patient / child cannot swallow the capsule, it is recommended to open it and dissolve the contents of the capsule in a small amount of liquid (tea, milk or juice).

For the prevention of infectious diseases of the respiratory tract:  the drug is used in three 10-day courses with 20-day intervals between them.

In the acute period of the disease:  assign 1 capsule/day until the disappearance of symptoms of the disease, but not less than 10 days. In the next 2 months, preventive use of the drug in 1 capsule for 10 days with a 20-day interval between courses is possible.

Overdose

There were no clinical symptoms of overdose.

There are no reports of intoxication due to drug overdose.

Special instructions

A 4-week interval should be observed between the use of oral vaccines and the use of Bronchomunal.

It is not recommended to use the drug in acute intestinal diseases due to the possible decrease in the effectiveness of the drug.

Use in pediatrics

The drug is not prescribed for children under 6 months of age. To avoid overdose, children from 6 months to 12 years are prescribed only Broncho-munal® P (capsules containing 3.5 mg of lyophilizate).

Influence on the ability to drive motor vehicles and manage mechanisms

No special precautions are required.

Form of production

Capsules

Storage conditions

At a temperature of 15-25 °C

Shelf life

5 years

Active ingredient

Bacterial lysates

Dosage form

Capsules

Description

Children as directed by a doctor, Children over 12 years of age, Adults as directed by a doctor

Indications

Respiratory Tract Infections, Tonsillitis, Sinusitis, Laryngitis, Runny Nose, Pharyngitis, Otitis Media, Bronchitis